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SUMMARY

Microglia are phagocytic cells that form the basis of
the brain’s immune system. They derive from primitive macrophages that migrate into the brain during
embryogenesis, but the genetic control of microglial
development remains elusive. Starting with a genetic
screen in zebrafish, we show that the noncanonical
NOD-like receptor (NLR) nlrc3-like is essential for
microglial formation. Although most NLRs trigger
inflammatory signaling, nlrc3-like acts cell autonomously in microglia precursor cells to suppress
unwarranted inflammation in the absence of overt
immune challenge. In nlrc3-like mutants, primitive
macrophages initiate a systemic inflammatory
response with increased proinflammatory cytokines
and actively aggregate instead of migrating into
the brain to form microglia. NLRC3-like requires
both its pyrin and NACHT domains, and it can bind
the inflammasome component apoptosis-associated speck-like protein. Our studies suggest that
NLRC3-like may regulate the inflammasome and
other inflammatory pathways. Together, these results demonstrate that NLRC3-like prevents inappropriate macrophage activation, thereby allowing
normal microglial development.
INTRODUCTION
As the only immune cells dedicated to the defense of the CNS,
microglia have unique functions and developmental origins
(Aguzzi et al., 2013; Ransohoff and Cardona, 2010). Microglia
are extremely sensitive to signs of infection, injury, and disease
of the brain, and they can respond rapidly, depending on the
nature of the stimulus (Ransohoff and Perry, 2009; Perry et al.,
2010). After infection, for example, microglia engulf pathogens
and initiate an immune response, and they can clear cell corpses
and promote healing after injury to the CNS. Microglia also
interact with and eliminate neuronal synapses, and they may

therefore modulate neuronal connectivity (Paolicelli et al.,
2011; Peri and Nüsslein-Volhard, 2008; Schafer et al., 2012; Ransohoff and Cardona, 2010). Unlike other CNS cell types, which
derive from the neuroectoderm, microglia arise from a subset
of primitive macrophages that migrates from the yolk sac into
the brain during embryogenesis (Ginhoux et al., 2010, Herbomel
et al., 2001). Primitive macrophages from the yolk sac in mouse
(Ginhoux et al., 2010) and zebrafish (Herbomel et al., 1999, 2001)
enter the brain prior to definitive hematopoiesis and differentiate
into microglia that remain in the brain thereafter (Ginhoux et al.,
2010). Because microglia in the adult brain derive from the early
embryonic macrophage population, early disruption of microglia
in the embryo may impair the immune system of the developing
and mature CNS. The cellular and molecular mechanisms, however, that mediate the specification, migration, and differentiation of developing microglia remain elusive.
NOD-like receptors (NLRs) are intracellular pattern-recognition receptors that regulate innate immunity and inflammatory
processes (Chen et al., 2009; Davis et al., 2011; Mason et al.,
2012). They can respond to pathogens and cellular stress by
triggering caspase-1-dependent inflammatory signaling or by
activating NF-kB to promote production of proinflammatory
cytokines (Chen et al., 2009; Davis et al., 2011). Upon recognizing various ligands, putatively through their C-terminal
leucine-rich repeats (LRRs) (Chen et al., 2009; Davis et al.,
2011; Mason et al., 2012), NLRs form large multiprotein complexes by self-oligomerization at their central NACHT domain.
Activated NLRs recruit other proteins through homotypic interactions with their N-terminal domains, typically either a pyrin or
a CARD domain, to activate NF-kB through the NODosome
pathway or caspase-1 through the inflammasome mechanism
(Chen et al., 2009; Davis et al., 2011). Mutations causing aberrant
NLR signaling are linked to numerous human inflammatory disorders, such as inflammatory bowel disease, vitiligo, sarcoidosis,
and cryopyrin-associated periodic syndromes (Chen et al.,
2009; Davis et al., 2011; Mason et al., 2012), underscoring the
importance of curbing inflammatory signaling mediated by the
NLRs. Recent studies have shown that NLRC3 and NLRP12
can suppress inflammation after challenge by lipopolysaccharide (LPS) or infection (Schneider et al., 2012; Allen et al., 2012;
Zaki et al., 2011). Despite the far-reaching roles of the NLRs in
controlling innate immunity, the mechanisms that regulate their
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Figure 1. Lack of Microglia in nlrc3-like
Mutants
(A and B) Live 5 dpf zebrafish larvae were
stained by neutral red to visualize microglia in the
brain.
(A) Heterozygous st73/+ larva (arrow points to
microglia around optic tectum) is shown.
(B) Homozygous st73 larvae have no microglia
(arrow). Dorsal views; anterior is to the top.
(C and D) Microglial marker apoe expression at
5 dpf in the brain is shown.
(E and F) Neutral red-stained heterozygous (E)
and homozygous mutant (F) shows normal
whole-animal morphologies at 5 dpf. Lateral
views; anterior is to the left.
(G) Genetic and physical map of the st73 locus.
(H) Sequence chromatogram shows the lesion
(asterisks) in the coding sequence of nlrc3-like
(LOC100538217).
(I) The st73 mutation introduces a premature stop
codon near the 50 end of the open reading frame of
nlrc3-like.
See also Figure S1.

functions and maintain homeostasis in the absence of infection
are not well understood.
Starting with a genetic screen for mutations that disrupt microglia in zebrafish, we identified a noncanonical NLR, nlrc3-like,
that is essential for microglia formation in zebrafish. Our analysis
demonstrates that nlrc3-like prevents runaway inflammation
during embryogenesis and thereby allows the development of
microglia. In nlrc3-like mutants, primitive macrophages adopt
an inflammatory phenotype instead of migrating into the brain
to differentiate as microglia. In addition, nlrc3-like mutants
have systemic inflammation, as evidenced by elevation of proinflammatory cytokines and recruitment of neutrophils into the
brain and circulation. Transgenic expression of the wild-type
nlrc3-like gene in macrophages rescued microglia in the
mutants, indicating that the gene acts autonomously in macrophages. Our results demonstrate that nlrc3-like serves as an
essential, cell-autonomous checkpoint in primitive macrophages that prevents unwarranted inflammation in the absence
of overt immune challenges and allows the normal development
of microglia.
RESULTS
nlrc3-like Is Essential for Microglia Development
In a genetic screen in zebrafish, we identified st73 as a recessive
mutation that eliminated microglia (Figures 1A and 1B). At 5 days
postfertilization (dpf), homozygous st73 mutant larvae lacked
microglial cells (Figures 1A–1D) but did not have any apparent
anatomical defects (Figures 1E and 1F). High-resolution meiotic
mapping localized the st73 mutation to a 1.63 Mb region of linkage group 15 (LG15) (Figure 1G). Among the genes in this interval
is nlrc3-like (LOC100538217) (Figure 1G), which encodes an
atypical member of the NLR family that contains the canonical
pyrin (PYD) and NACHT domains but lacks the common LRRs
thought to be important for ligand sensing and self-inhibition

(Davis et al., 2011; Mason et al., 2012). NLRC3-like belongs to
an expanded subfamily of teleost NLRs that shares significant
similarity to the human NLRC3 (or Nod3), based on sequence
comparisons of the NACHT domain (Laing et al., 2008; Hughes,
2006). Sequence analysis identified a nonsense mutation in
nlrc3-like near the 50 end of the open reading frame (Figures
1H and 1I). All st73 mutants analyzed were homozygous for
this lesion (n = 300). Injection of synthetic mRNA encoding the
wild-type NLRC3-like protein can fully rescue microglia in st73
mutants and had no effect on wild-type siblings (Figure S1). On
the basis of mapping, the identification of the nonsense lesion,
and RNA rescue experiments, we conclude that st73 is a lossof-function mutation in the nlrc3-like gene.
Abnormal Migration and Inflammatory Activation of
Macrophages in nlrc3-like Mutants
To define the role of nlrc3-like in microglia development, we
examined different stages of microglia development starting
from the formation of primitive macrophages to differentiation
of microglia (20–60 hr postfertilization [hpf]) using markers
specific to macrophages (microfibrillar-associated protein 4
[mfap4] and macrophage-expressed gene 1 [mpeg1]) (Ellett
et al., 2011; Zakrzewska et al., 2010) and all leukocytes (l-plastin)
(Meijer and Spaink, 2011). We detected no difference in macrophage, neutrophil, or overall leukocyte number and distribution,
vasculature formation, or blood circulation between mutants and
their wild-type siblings at early time points up to 24 hpf (Figure S2;
data not shown). By 2 dpf, however, mutant macrophages
aggregated in large clusters on the yolk (Figures 2A–2C and
S2). Time-lapse imaging revealed that macrophages actively
migrated toward and joined these aggregates in the mutant, in
clear contrast to wild-type siblings, in which no aggregation
occurred (Figure 2C; Movies S1 and S2). Other macrophages
in mutants migrated from the yolk, but they often still formed
small clusters (Figure 2E, arrowheads). These macrophages
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Figure 2. Aberrant Migration of Primitive
Macrophages in nlrc3-like/ Mutants
(A) Diagram shows the stereotypical migration
route of macrophages from yolk sac to embryo
proper (arrows).
(B) Fluorescent images show abnormal active
coalescence of yolk sac macrophages (mpeg1:
EGFP+ in green, arrows) that overlap with
apoptotic marker TUNEL in red in mutants (bottom
panel; n = 12/12), which does not occur in wildtype (top panel; n = 11/11). Region of imaging is
indicated by yellow box in (A).
(C) Trajectories of individual yolk sac macrophages are shown using the MTrackJ cell-tracking
tool, where the end point is indicated by a solidtriangle marker. See Movies S1 and S2 for the
time-lapse series.
(D) Time-lapse imaging shows the head region
(red box in A) where macrophages are expected
to migrate into the brain, using transient transgenesis of the mpeg1:EGFP construct labeling
macrophages in green and the stable transgene
kdrl:mCherry-CAAX to visualize the vasculature in
red. Imaging shows macrophages entering the
brain in wild-type siblings (top) but not mutant
(bottom). The numbers indicate the time
in minutes. In the top panels, the arrowhead points
to a macrophage that has taken up residence in the
brain to become a microglial cell; the arrow points
to another macrophage migrating into the brain. In
the bottom panels, the arrow points to a mutant
macrophage that does not enter the brain and remains associated with vasculature (as demarcated
by dotted lines). See Movies S3 and S4.
(E) Whole-mount in situ hybridization at 2.5 dpf
shows macrophage mfap4+ and microglial
apoe+ cells in wild-type heterozygous embryos
(arrows), but not in mutants (arrows). Aberrant
macrophage clusters form near cranial vasculature in mutants (arrowheads). MB, midbrain; HB,
hindbrain.
See also Figure S2 and Movies S1–S4.

typically did not enter the brain parenchyma in the mutants but,
instead, remained associated with the vasculature (Figure 2D;
Movies S3 and S4). Macrophage and microglia markers (mfap4
and apoe, respectively) confirmed the absence of brain macrophages and microglia through 2.5 dpf, even though peripheral
macrophages were present (Figure 2E). The formation of aggregates is characteristic of macrophages activated by infection or
injury (Renshaw and Trede, 2012). We also observed that macrophages in mutants formed large cytoplasmic vacuoles, often
several per cell (Figures 3A–3C), and that a higher fraction of
macrophages were TUNEL positive at 2.5 dpf in mutants than
in sibling controls (Figures 3C–3E). TUNEL-positive macrophages in the mutants exhibited condensed apoptotic nuclei
(Figure 3D) or cellular breakdown (Figure 3E), two characteristics
of an inflammatory form of apoptosis called pyroptosis (Lamkanfi
and Dixit, 2010; Lage et al., 2013). The number of macrophages
in the mutants declined significantly by 3–4 dpf (Figure 3F),
consistent with an increase in apoptotic macrophages. The
active aggregation, vacuolation, and pyroptotic death of macrophages in nlrc3-like mutants resemble phenotypes previously

described for macrophages responding to infection (Mujawar
et al., 2006; Siracusa et al., 2008; Lage et al., 2013; Renshaw
and Trede, 2012), suggesting that nlrc3-like mutant macrophages are activated despite the absence of overt infection.
Because macrophage activation is a prominent component
of the inflammatory immune response after infection or injury
(Mosser and Edwards, 2008), we examined whether the macrophage abnormalities in nlrc3-like mutants were linked to inappropriate inflammation. Using quantitative PCR (qPCR), we found a
highly significant increase in all proinflammatory cytokines
tested (il-1b, il-8, il-12a, and tnfa) (Rock et al., 2010), but no
detectable change in expression of the b-actin control or the
anti-inflammatory cytokine il-10 (Moore et al., 2001) in the
mutants relative to wild-type siblings (Figure 3G; data not
shown). The highly elevated expression of proinflammatory cytokines indicated that macrophages in the mutants were activated
in the context of an inflammatory environment. These inappropriately activated embryonic macrophages (microglia precursor
cells) do not migrate properly and undergo premature cell death,
thus accounting for the lack of microglia in nlrc3-like mutants.
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Figure 3. Inappropriate Inflammatory Activation of Macrophages in nlrc3-like/ Mutants
(A and B) High-magnification images show striking cell morphology differences between yolk sac macrophages of wild-type (A) and mutant (B). Macrophages in
the mutants have multiple, large vacuoles (arrows).
(C) Plot shows significantly higher percentages of primitive macrophages (mpeg1-EGFP+) exhibiting vacuolation (one or more large cytoplasmic vacuoles;
p = 0.047) and cell death (overlap of TUNEL staining with macrophage DAPI staining; p = 0.037) in nlrc3-like/ mutants (n = 5 embryos) compared with siblings
(n = 6 embryos). Statistical significance was determined by the two-tailed Student’s t test.
(D and E) Examples of dying mutant macrophages exhibiting apoptosis (arrow in D), and cellular breakdown (arrows in E) are shown.
(F) Plot shows macrophage number over time. Diagram indicates the region of quantification (colored boxes): n = 5 for each genotype at 1 and 2.5 dpf, p = 0.0009
at 2.5 dpf; at 3–4 dpf, n = 7 siblings and n = 3 mutants (p = 2 3 105).
(G) Graph shows relative mRNA levels of proinflammatory cytokines by qPCR comparing mutants (n = 6) to wild-type siblings (n = 6) at 3 dpf. p = 0.70 (b-actin),
p = 0.002 (il-1b), p = 0.004 (il-8), p = 0.008 (il-12a), and p = 0.03 (tnfa).
n, number of independent embryos analyzed. Error bars show SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. All p values are two tailed.

Systemic Inflammation in nlrc3-like Mutants
The abnormal activation of macrophages in nlrc3-like mutants
raised the possibility of a broader dysregulation of the immune
system. To investigate whether other immune cells are disrupted
in nlrc3-like mutants, we examined neutrophils, the only other
mature leukocyte present during embryonic stages, before the
adaptive immune system is functional (Lam et al., 2004).
Whereas neutrophils were excluded from the brain of wild-type
embryos, they aberrantly infiltrated the brains of nlrc3-like
mutants (Figure 4), as demonstrated by examination of the
neutrophil markers myeloperoxidase (mpo) and lysozyme C
(lyz) (Meijer and Spaink, 2011). In vivo time-lapse imaging of
the neutrophil reporter transgene lyz:EGFP (Hall et al., 2007) (Figures 4A–4F; Movies S5 and S6) revealed neutrophils freely roaming in the brain of nlrc3-like mutants. Quantitation of lyz:EGFP+
neutrophil numbers revealed a significant number of brain neutrophils in nlrc3-like mutants, compared with essentially none
in wild-type siblings (Figure 4G). Transverse sections confirmed
the mislocalization of mutant neutrophils in the brain parenchyma and around vasculature (Figure S3). In addition to brain
infiltration, live imaging in nlrc3-like mutants also revealed a
highly significant increase of neutrophils in circulation (Figures
4H–4J; Movies S7 and S8), starting as early as 1.5 dpf, when
primitive macrophages begin to enter the brain in wild-type embryos. Using markers to distinguish neutrophils (lyz:EGFP+ and
pan-leukocyte marker L-plastin+) and macrophages (L-plastin+
only), we also found that neutrophils joined the aberrant aggregates of macrophages described above (Figures 2B, 2C, and

4K). The increase of neutrophils in circulation, infiltration of neutrophils into the brain, intermixing of neutrophils and macrophages in abnormal aggregates, and extremely high levels of
proinflammatory cytokines collectively indicate systemic inflammation in nlrc3-like mutants.
nlrc3-like Acts Autonomously in Macrophages to
Mediate Normal Microglia Development
In light of such systemic inflammation, we sought to determine
whether NLRC3-like acts within macrophages or in other cell
types. Using transient Tol2-mediated transgenesis in nlrc3-like
mutants, we introduced constructs that expressed either the
wild-type nlrc3-like or control mCherry coding sequence in
skin, neurons, neutrophils, or macrophages using cell-type-specific regulatory elements (Figures 5A, 5B, and S4). Expression of
the wild-type nlrc3-like gene in macrophages rescued microglia
(>20 microglia/embryo; 24% of the mutants, n = 55), but expression in the other cell types did not (Figure 5). Partial rescue (10–
20 microglia/embryo) was also observed in 11% of mutants
injected with the macrophage expression construct (Figure 5B).
There was one case of partial rescue with the neuronal nlrc3-like
expression construct (among 25 mutants examined), perhaps
due to leaky promoter expression (Figure 5B). No rescue or partial rescue was obtained with any of the control mCherry expression constructs (Figure 5B). Driving nlrc3-like expression using
the myeloid lineage-specific pu.1/spi1-GAL4 line also rescued
microglia in the mutants, providing further evidence that nlrc3like is required in macrophages (Figure S4).
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Figure 4. Systemic Inflammation in nlrc3like/ Mutants in the Absence of Infection
or Injury
(A and B) Neutrophil-specific marker mpo shows
no brain neutrophils in wild-type siblings (arrow, A)
but abundant infiltration in mutants (arrow, B).
Lateral views, anterior to the left.
(C and D) Representative frames from time-lapse
imaging in the intact 2.5 dpf embryos (see Movies
S5 and S6) show wandering neutrophils (lyz:EGFP)
in the brain of mutants (D) but none in wild-type
(C), with reference to vasculature (kdrl:mCherryCAAX). Dorsal views, anterior to the top.
(E and F) Higher magnification shows GFP
channel alone (dotted-box region in C and D,
respectively).
(G) Plot shows that high numbers of neutrophils
infiltrate the brain in mutants (n = 15) but nearly
zero in wild-type (n = 16; p = 0.0018).
(H and I) Representative images show live imaging
of neutrophils at 1.5 dpf in wild-type sibling (H) and
in mutant (I). (I) Mutant embryos show large
numbers of neutrophils in brain (asterisk) and circulation (arrows). Lateral views, anterior to the top.
ey, eye; mb, midbrain; ot, otic vesicle.
(J) Plot shows significantly higher numbers of
circulating neutrophils in mutants (n = 4) compared
with wild-type (n = 5; p = 0.0083).
(K) Neutrophils (lyz:EGFP as pseudocolored in red)
are closely intermixed with the aberrantly coalescing macrophages (L-plastin expression only
as shown in green) in the mutants, whereas wildtype neutrophils are dispersed and not clustered
with macrophages.
n, number of embryos analyzed. Error bars show
SEM. **p < 0.01. All p values are two tailed.
See also Figure S3 and Movies S5–S8.

nlrc3-like Continues to Be Required after Microglial
Progenitors Enter the Brain and Differentiate
To test whether nlrc3-like is required after macrophages have
entered the brain and differentiated as microglia, we transiently
restored wild-type nlrc3-like expression by synthetic mRNA injection at the one-cell stage. Injection of nlrc3-like mRNA into
mutants can restore microglia at 5 dpf and earlier stages (Figure S1; data not shown). By contrast, at 6 dpf, no mutants
injected with nlrc3-like mRNA exhibited wild-type numbers of
microglia (n = 45), and more than half of the injected mutants
had no microglia detectable by neutral red staining (Figure 5C).
Consistent with a continuous requirement in microglia development, nlrc3-like mRNA is expressed at every stage we examined
in wild-type embryos, from embryogenesis through the early
larval period (1–9 dpf; Figure S5). These data indicate that
nlrc3-like continues to be required to maintain the proper number
of microglia at later stages.
To assess inflammation in nlrc3-like mutants at later stages,
we measured cytokine expression by qPCR. As at 3 dpf (Figure 3G), transcripts for il-1b, il-8, and tnfa were significantly

elevated in nlrc3-like mutants at 6 dpf,
but il-12a expression was similar to
wild-type siblings (Figure 5D). To determine whether early expression of wild-type nlrc3-like is sufficient to suppress inflammation at later stages, we also
examined cytokine levels in mutants injected with nlrc3-like
mRNA. Proinflammatory cytokine expression at 6 dpf was
elevated relative to wild-type controls, and the extent of the
increase correlated with the number of microglia in the transiently rescued mutants (Figure 5D). In these transient rescue
experiments, mutants with more than ten detectable microglia
had significantly lower levels of il-8 and tnfa (p = 0.01 and
0.03, respectively) than mutants with no microglia. These data
indicate that nlrc3-like continues to be required to suppress
inflammation and allow the development of the full population
of microglia, even after microglia progenitors have entered
the brain and differentiated.
Macrophages Are Required for Increased Inflammatory
Signaling in nlrc3-like Mutants
The autonomous action of nlrc3-like in the macrophage lineage
and the integral roles of macrophages in mediating and
responding to inflammation (Rock et al., 2010; Mosser and
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Figure 5. nlrc3-like Has an Autonomous and Continuous Function in Macrophages that Become Microglia
(A) Top view is a diagram of transgenic constructs driving either control mCherry or nlrc3-like expression by tissue-specific gene promoters in skin (keratin 4/krt4),
neurons (elavl3/huC), neutrophils (lyz), or macrophages (mpeg1). Bottom view is representative images showing rescue of neutral red-positive microglia in nlrc3like/ mutants when expression of wild-type nlrc3-like is restored in macrophages (right), but not by control mCherry expression (left).
(B) Plot quantifies the percentage of microglia rescue using different tissue-specific expression vectors. Ctrl, control mCherry injected; NLR, nlrc3-like construct
injected.
(C) Images and plot show microglia by neutral red staining at 6 dpf, after nlrc3-like mRNA injection at the one-cell stage. Injected nlrc3-like/ mutants show no
microglia or partial rescue (more than five microglia) at 6 dpf, but no mutants are rescued to the wild-type level. In contrast, RNA injection does fully rescue
microglia in some mutants at earlier stages (Figure S1).
(D) Graph shows relative proinflammatory transcript levels after transient rescue of nlrc3-like/ mutants by injection of wild-type nlrc3-like mRNA at onecell stage. Injected mutants with no microglia at 6 dpf have elevated levels of proinflammatory cytokine transcripts that are similar to uninjected mutants.
In contrast, mutants with partial rescue of microglia at 6 dpf have lower levels of il-8 and tnf-a expression, indicating that the number of microglia correlates
inversely to the extent of inflammatory cytokine expression. Individual plots are normalized to their corresponding wild-type siblings, either uninjected or
injected.
Numbers below bar graphs represent n, number of embryos analyzed. Error bars show SEM. *p < 0.05, one-tailed Student’s t test. n.s., not significant.
See also Figures S4 and S5.

Edwards, 2008) prompted us to ask whether macrophages
contributed to the systemic inflammation in nlrc3-like mutants.
We thus examined proinflammatory cytokine expression after
ablating macrophages in nlrc3-like mutants with a morpholino
(MO) against interferon regulatory factor-8 (irf8) (Li et al., 2011)
(Figure 6A). Macrophage ablation reduced il-1b expression in
nlrc3-like mutants to wild-type levels (Figure 6B). In control
assays, macrophage ablation in wild-type embryos did not alter
il-1b levels, whereas il-1b expression remained elevated in
unablated mutants (Figure 6B), consistent with our previous
analysis (Figure 3G). All other proinflammatory cytokines (il-8,
il12a, and tnfa) examined were also comparable to wild-type
levels in macrophage-ablated mutants (Figure 6B). Taken
together, these results demonstrate that macrophages are
required for the increased inflammatory signaling in nlrc3-like
mutants.

NLRC3-like Requires Both the Pyrin and NACHT
Domains and May Interact with the Inflammasome
Component ASC
The inflammatory phenotypes of nlrc3-like mutants suggested
that this unusual NLR family member might regulate the
production of proinflammatory cytokines and induction of
pyroptosis by inhibiting the inflammasome (Davis et al., 2011).
Previous in vitro studies indicate that cellular and viral proteins with similar domain organizations, containing only the
PYD or PYD combined with NACHT, can inhibit the inflammasome through homotypic interactions with other inflammasome components containing these domains (Dorfleutner
et al., 2007a, b; Imamura et al., 2010; Stehlik et al., 2003). To
examine the possibility that NLRC3-like interacts with components of the inflammasome, we asked whether NLRC3-like protein can bind to the PYD-containing adaptor protein of the
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Figure 6. NLRC3-like Negatively Regulates
Inflammatory Signaling through Macrophages and May Interact with the Inflammasome Component ASC and Other Pyrin and
NACHT-Containing Proteins
(A) Macrophage mfap4 expression shows complete macrophage ablation by irf8 MO injection at
2 dpf (arrow). Injected wild-type embryos show
complete loss of neutral red-positive microglia
(n = 29/29; data not shown).
(B) Graph shows relative il-1b mRNA levels, with
pairwise comparisons indicated by the dotted
lines. Depletion of macrophages in nlrc3-like
mutants (mut) reduces il-1b and other proinflammatory cytokine levels similar to wild-type
(WT) levels. sib, siblings.
(C) SDS-PAGE analyses of reciprocal pull-down
assays show binding of zebrafish ASC with
NLRC3-like (lanes 2 and 4) and minimal binding to
tag-alone controls (lanes 1 and 3). MBP-tagged
full-length NLRC3-like runs near 160 kDa (blue
arrowhead) with several smaller processed forms;
GST-ASC at 50 kDa; MBP alone from pMAL-c2X
vector at 50 kDa; and GST alone at 30 kDa. Blot
shows 0.4% of the input prey protein per lane.
(D) Top view is a schematic of the wild-type
NLRC3-like protein and deletion versions: NLRC3like- Dpyrin with deletion at amino acids (aa)
230–269 and NLRC3-like-DNACHT with deletion at aa 357–518. At the bottom is a bar graph showing rescue of st73 mutants (87.5%, n = 16) by injection of mRNA
encoding wild-type NLRC3-like, but none using the mutant constructs. Numbers at left edge of bar graphs represent n, number of embryos analyzed.
Error bars show SEM. *p < 0.05.

inflammasome, apoptosis-associated speck-like protein (ASC)
(Davis et al., 2011). Reciprocal pull-down assays showed that
glutathione S-transferase (GST)-tagged zebrafish ASC and
maltose-binding protein (MBP)-tagged NLRC3-like can bind
(Figure 6C). The unusual pyrin-NACHT structure of NLRC3like, the systemic inflammation in nlrc3-like mutants, and the
potential interaction between the NLRC3-like and ASC proteins
suggest that NLRC3-like may negatively regulate inflammasome activity or other pathways mediating inflammatory
signaling that involve ASC (Sarkar et al., 2006; Kolly et al.,
2009).
To determine which domains may be essential for nlrc3-like
function, we performed a structure-function analysis. We
designed deletion constructs that express mRNAs encoding
NLRC3-like proteins that lack either the NACHT domain (Nlrc3like-DNACHT) or the pyrin domain (Nlrc3-like-Dpyrin), which
are the two recognizable conserved domains in NLRC3-like.
Wild-type nlrc3-like mRNA injection can fully rescue microglia
in nlrc3-like mutants at 3–5 dpf (Figures 6D and S1), and we
assayed the ability of mRNAs encoding the deletion mutants to
rescue nlrc3-like mutants (Figure 6D). Both domains are required
to rescue nlrc3-like mutants (Figure 6D), providing evidence that
the pyrin and NACHT domains are both essential for NLRC3-like
function. The requirement for the pyrin domain supports the
possibility that NLRC3-like may functionally interact with other
pyrin-containing proteins such as ASC (Dorfleutner et al.,
2007a; Vajjhala et al., 2012; Liepinsh et al., 2003), and the
requirement for the NACHT domain indicates that NLRC3-like
may also interact with itself or other NLR proteins that regulate
inflammatory signaling.

LPS Challenge Compromises Microglia Development in
nlrc3-like Heterozygous Embryos
To further test the relationship between systemic immune activation and nlrc3-like function, we injected LPS into the bloodstream of embryos from nlrc3-like+/ heterozygous intercrosses
at 1 and 2 dpf and analyzed microglial development at 3 dpf. LPS
injection reduced microglia formation in many of the injected
nlrc3-like+/ heterozygous embryos (54%, n = 24) and affected
one of nine injected wild-type siblings (11%) (Figure 7). These
data indicate that nlrc3-like+/ heterozygotes are more susceptible to disruptions of microglia development when exposed to the
LPS inflammatory stimulus than wild-type siblings. These results
are consistent with the autonomous function of nlrc3-like in the
macrophage lineage (Figures 5A and 5B) but also show that
extrinsic inflammatory stimuli can disrupt the development of
microglia when nlrc3-like function is partially reduced.
DISCUSSION
Macrophages utilize an array of pattern-recognition receptors,
including the Toll-like receptors (TLRs) and NLRs, to recognize
and respond rapidly to infection, injury, and cellular stress
(Chen et al., 2009; Davis et al., 2011; Mosser and Edwards,
2008). The signaling activities of these receptors must be regulated to maintain homeostasis and prevent inappropriate or
chronic inflammation. Previous studies show that TLR signaling
is attenuated through multiple mechanisms, including production of decoy receptors and inhibitors of downstream signaling
complexes (Anwar et al., 2013; Coll and O’Neill, 2010). Much
less is known about the negative regulation of NLRs in vivo,
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Figure 7. Exposure of nlrc3-like Heterozygous Embryos to Systemic
LPS Challenge Disrupts Microglia Development
(A) Neutral red staining at 3 dpf shows normal formation of microglia in control
uninjected nlrc3-like heterozygous embryos. In contrast, many nlrc3-like heterozygous embryos injected with LPS at 1 and 2 dpf have strongly reduced
(6–16 microglia) or eliminated (0–5 microglia) microglia.
(B) Bar graph shows the frequency of loss of microglia in nlrc3-like heterozygous fish injected with LPS, compared with little effect on the wild-type
siblings.

despite their critical roles in controlling innate immunity (Chen
et al., 2009; Davis et al., 2011; Coll and O’Neill, 2010). Our results
demonstrate that nlrc3-like is an essential negative regulator of
macrophage activation and inflammation. Loss of NLRC3-like
causes an inflammatory state in macrophages that profoundly
alters their normal course of development. Instead of seeding
the brain to form microglia, embryonic macrophages in the
mutant actively migrate to form aberrant cellular aggregations
in the yolk, fail to enter the brain, and eventually undergo
inflammatory cell death. Activity of nlrc3-like continues to be
required even after microglial progenitors enter the brain and
differentiate because transient expression of the wild-type
gene is not sufficient for long-term rescue of microglia or suppression of inflammation. These results highlight the importance
of regulating the activation of embryonic macrophages to allow
normal microglia development, in addition to the more widely
recognized need to control activation of adult microglia to
prevent chronic or acute inflammation that is common in
many neurodegenerative and autoimmune diseases such as
Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
(Cunningham, 2013; Amor et al., 2010).
Our data support a model in which NLRC3-like competes with
proinflammatory NLRs for ASC binding to set a threshold level of
activated canonical NLRs required to trigger inflammation.
According to this view, NLRC3-like would prevent widespread
inflammation in response to limited or transient stimuli, such as
exposure to nonpathogenic microbes, but still allow rapid initiation of inflammation when NLRs are activated by a robust stim-

ulus such as an injury or infection. This model is also consistent
with the proposed mechanism of cellular and viral proteins containing only the pyrin domain, only the NACHT domain, or a pyrin
and NACHT, which inhibit the inflammasome through homotypic
binding (Dorfleutner et al., 2007a, b; Imamura et al., 2010; Stehlik
et al., 2003). Furthermore, similar to these inflammasome inhibitory proteins, NLRC3-like has a distinctive pyrin-NACHT structure that lacks the canonical LRRs thought to be important for
self-inhibition (Rosenstiel et al., 2007; Chen et al., 2009), suggesting that it may be a constitutively active inhibitor. Our structure-function analysis indicates that both the pyrin and NACHT
domains are required for NLRC3-like function, suggesting that
NLRC3-like may interact with other proteins containing one or
both of these domains, including the adaptor ASC.
The zebrafish genome contains a large number of NLR genes
homologous to mammalian NLRC3 (Laing et al., 2008), and our
analysis provides functional insights into this group of zebrafish
NLRC3-like genes. Although its NACHT domain is most similar
to the mammalian NLRC3 (Laing et al., 2008; Hughes, 2006),
the central NACHT domain is the only major region conserved
between the zebrafish NLRC3-like and mammalian NLRC3 proteins. Moreover, the zebrafish NLRC3-like protein has only pyrin
and NACHT domains, whereas the mammalian NLRC3 has
C-terminal LRRs but lacks an N-terminal effector motif. Our
biochemical studies suggest that zebrafish NLRC3-like may suppress inflammation by interfering with interactions between ASC
and other inflammasome components. The mammalian NLRC3
protein can also suppress inflammation. A recent study shows
that NLRC3 reduces TLR signaling and NF-kB activity after
LPS exposure through its interaction with TRAF6 (Schneider
et al., 2012). It is also possible that zebrafish NLRC3-like regulates NF-kB activation in an inflammasome-independent manner
because highly elevated levels of mRNAs for proinflammatory
cytokines were detected in nlrc3-like-deficient embryos. Consistent with this possibility, zebrafish NLRC3-like has three
predicted TRAF-interaction motifs (following the consensus
Pro/Ser/Ala/Thr-X-Gln/Glu-Glu). Thus, NLRC3-like may repress
NF-kB activity by interference with TRAF adaptor proteins in
the recruitment of NF-kB, similar to the anti-inflammatory action
of NLRC3 and NLRP12 after immune stimulation (Schneider
et al., 2012; Allen et al., 2012; Zaki et al., 2011). Alternatively,
inappropriate activation of the inflammasome may secondarily
induce cytokine expression in nlrc3-like mutants.
Another important and intriguing difference between zebrafish
nlrc3-like and the mouse NLR genes known to suppress inflammation, including NLRC3 and NLRP12 (Schneider et al., 2012;
Allen et al., 2012; Zaki et al., 2011), is that the mouse hyperinflammatory mutant phenotypes are evident only after LPS injection or infection, whereas systemic inflammation is found in
nlrc3-like mutant zebrafish in the absence of immune perturbation. Under standard rearing conditions, wild-type and heterozygous siblings show no signs of inflammation, but nlrc3-like
mutants display severe, systemic dysregulation of the immune
system. This difference reveals that nlrc3-like is an essential
suppressor of inflammation at steady state, highlighting the
importance of the regulatory mechanism that controls immune
activation not only in response to overt immune challenges but
also during normal development.
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In summary, we identify an essential role for an NLR that acts
as a checkpoint on inflammatory processes and permits the
development of microglia in zebrafish. Our analysis of nlrc3like mutants highlights the deleterious effect that inflammatory
activation has on embryonic macrophages and their subsequent
development into microglia. The negative regulatory function of
NLRC3-like may provide important insights into the maintenance
of homeostasis and the etiology of autoimmune and inflammatory disorders.
EXPERIMENTAL PROCEDURES
Zebrafish Lines and Embryos
Experimental protocols involving zebrafish were approved by the Stanford
University Institutional Animal Care and Use Committee. Embryos from wildtype (TL, AB/TU, and WIK), Tg(lyz:EGFP) (Hall et al., 2007), Tg(mpeg1:EGFP)
(Ellett et al., 2011), Tg(kdrl:mCherry-CAAX) (Fujita et al., 2011), Tg(pu.1:Gal4UAS-EGFP) (Peri and Nüsslein-Volhard, 2008), and nlrc3-likest73/+ strains
were raised at 28.5 C and staged as described by Kimmel et al. (1995).
Embryos were treated with 0.003% 1-phenyl-2-thiourea (PTU) in methylene
blue embryo water to inhibit pigmentation.
ENU Mutagenesis, Microglia Screen, and Neutral Red Assay
Founder P0 wild-type males were mutagenized with N-ethyl-N-nitrosourea
(ENU) and subsequently outcrossed to raise F1 and F2 families for screening
as described by Pogoda et al. (2006). A pilot F3 genetic screen was conducted
to identify putative mutants with specific defects in microglia (e.g., loss of
microglia), but no apparent anatomical morphological defects at 5 dpf. A total
of 74 F2 families were screened, which amounted to analysis of 50.7 mutagenized genomes. Two putative microglia mutants were identified, but only st73
was recovered. Microglia were scored in the live larvae by a neutral red vital
dye-staining assay (Herbomel et al., 2001) with modifications. For phenotypic
analyses, neutral red assay was used at 3 dpf and later stages by incubating
larvae in embryo water containing 2.5 mg/ml neutral red at 28.5 C for 2–3 hr,
followed by one to two water changes, and then analyzed 0.5–24 hr later using
a dissecting microscope.
Genetic Mapping
st73 mutant embryos were phenotypically sorted from wild-type siblings at 4–5
dpf by a lack of neutral red-positive microglia staining in the head. Bulk segregant analysis with 480 simple sequence length polymorphisms (SSLPs) (Talbot
and Schier, 1999) identified markers on LG15 flanking the st73 mutation. Highresolution mapping was conducted using additional SSLPs and singlenucleotide polymorphisms linked to the mutation, which were found from
sequencing PCR fragments amplified from genomic DNA of mutants and
wild-type siblings. Sequencing segments of genes in the critical interval by
PCR from genomic DNA templates identified the st73 lesion in the nlrc3-like
gene (LOC100538217). Genotyping the st73 lesion is based on a PCR/restriction digest assay using the following forward and reverse PCR primers and
MseI digest: 50 -CAACAATTTCATCAAAATCTTCAA-30 and 50 -CAGACATATT
CTGGAAGCAAACA-30 , respectively.
Whole-Mount RNA In Situ Hybridization
In situ hybridization on whole-zebrafish embryos and larvae from 20 hpf to
5 dpf was performed using standard methods as described by Pogoda et al.
(2006). Antisense riboprobes were transcribed from the following gene-coding
sequences cloned in pCRII-Topo vector: lyz (518 bp); mfap4 (627 bp using
primer sequences as described by Zakrzewska et al., 2010); l-plastin
(1,541 bp of lcp1); and apoe (505 bp of apoeb). Other probes were made
from vectors encoding mpo (full-length, Open Biosystems clone 6960294)
and kdrl (flk1) (Thisse et al., 2008).
Whole-Mount Immunostaining and TUNEL Assay
TUNEL assay (In Situ Cell Death Detection Kit, TMR red; Roche) was performed as previously described by Chen et al. (2010). Subsequent immuno-

staining on whole-zebrafish embryos or larvae was performed using the
anti-L-plastin (Redd et al., 2006) at 1:250–500 dilution and anti-GFP (GT859;
GeneTex) at 1:500 dilution, followed by DAPI staining.
Time-Lapse and Fluorescent Imaging
For live imaging, embryos were embedded in 1.5% low-melting point agarose
on glass slides. For cryosectioning, postfixed embryos were equilibrated to
30% sucrose, embedded in OCT medium, snap frozen in dry ice-ethanol
bath, sectioned at 10–12 mm, and subsequently imaged. All time-lapse and
fluorescent images, except images for analysis of vacuolation and apoptosis,
were taken on a Zeiss LSM 5 Pascal confocal microscope using the 103 (NA
0.30) and 203 (NA 0.75) objectives, and 488 and 543 nm laser lines with bright
field. Images of yolk sac macrophages for assessing cellular vacuolation and
cell death were taken on an upright Zeiss Axio Imager.M2 microscope using
the 203 (NA 0.8) and 633 (NA 1.4) plan-apochromatic objectives. See also
the Supplemental Experimental Procedures for additional information.
Expression Constructs
Full-length nlrc3-like-coding sequence (XM_003200091.1) was cloned from a
2.5 dpf embryonic cDNA pool and directionally inserted into the pCS2+
plasmid at XhoI/XbaI sites to make pCS2-FL-nlrc3-like for mRNA transcription.
Truncated forms (pCS2-nlrc3-like-Dpyrin and pCS2-nlrc3-like-DNACHT) were
made using fusion PCR and also directionally cloned into the pCS2+ plasmid
at XhoI/XbaI sites. All transgenic expression constructs contained the Tol2transposon sequences for genomic integration. Primers used in cloning are
listed in Table S1. See also Supplemental Experimental Procedures for further
details.
mRNA, Plasmid, and MO Injections
pCS2-FL-nlrc3-like and truncated forms (pCS2-nlrc3-like-Dpyrin and pCS2nlrc3-like-DNACHT) were transcribed using the Sp6 mMessage machine
(Ambion) to produce 50 capped mRNAs with a poly-A tail. A range of 50–
200 pg of nlrc3-like mRNA was injected into one- to four-cell stage embryos;
all amounts of RNA tested in this range can rescue microglia in nlrc3-like
mutants. Structure-function analysis was conducted using injections of 150–
200 pg of mRNA in one- to two-cell stage embryos. Transgenes were transiently expressed by coinjecting 12–25 pg of Tol2 plasmid as described
above and 50–100 pg of Tol2 transposase mRNA at one-cell stage. A
splice-blocking MO against irf8 was synthesized by Gene Tools and was
injected at 2.5–5 ng into one-cell stage embryos as previously described by
Li et al. (2011). As negative controls, embryos were injected with water or
not injected.
RNA Extraction, RT-PCR, and qPCR
Total RNA was extracted from individual embryos using the RNAqueous-Micro
RNA Isolation Kit (Ambion). Embryos were presorted by neutral red phenotype
prior to lysis and genotyped using a PCR-restriction digest assay as described
above. cDNA was made using oligo dT primer and SuperScript II or III Reverse
Transcriptase (Invitrogen). qPCR was performed on the ABI 7300 Real-Time
PCR System or the Bio-Rad CFX384 Real-Time PCR Detection System with
SYBR GreenER qPCR reagent (Invitrogen). Additional information is provided
in the Supplemental Experimental Procedures.
Protein-Interaction Pull-Down Assay
DNA constructs were made using modified Gateway vectors (Meireles et al.,
2009). GST-ASC fusion protein containing the full-length zebrafish ASC
sequence (NM_131495.2) was made in pGEX-4T-1 vector. Full-length
NLRC3-like protein (XP_003200139.1) was fused to MBP using the vector
pMAL-c2X. All proteins were expressed in Escherichia coli BL-21 cells (Invitrogen) using IPTG induction. See also the Supplemental Experimental Procedures for more details.
LPS Microinjection
A total of 3–5 nl of LPS from Pseudomonas aeruginosa 10 (Sigma-Aldrich) at
5 mg/ml in PBS with rhodamine dextran (10,000 MW at 1:5 dilution) was injected into the circulation valley (duct of Cuvier) as described by MilliganMyhre et al. (2011). Embryos were injected at 22–24 hpf and at 48 hpf;
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detection of the fluorescent dextran throughout vasculature was used to
select for successful injections for later analysis. Injected embryos and control
uninjected siblings were analyzed at 3 dpf using the neutral red assay for
microglia.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, one table, and eight movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2013.11.004.
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